期刊文献+

EphA2和E-cadherin在膀胱尿路上皮癌中的表达及意义 被引量:2

Expression and significance of EphA2 and E-cadherin in bladder urothelium carcinoma
下载PDF
导出
摘要 目的:探讨生促红素人肝细胞A2(erythropoietin-producing human hepatocelluar A2,EphA2)和E-钙黏蛋白(E-cadherin)在膀胱尿路上皮癌(bladder urothelium carcinoma,BTCC)中的表达及临床意义。方法:应用免疫组织化学方法检测10例正常膀胱黏膜和50例BTCC标本EphA2和E-cadherin表达情况。结果:10例正常膀胱黏膜标本中EphA2表达均为阴性,而E-cadherin表达为正常表达;50例BTCC标本中EphA2和E-cadherin异常表达率分别为80.0%、56.0%。EphA2表达与分级和分期间差异均有统计学意义(P<0.05),与淋巴结转移无明显关系(P>0.05);E-cadherin表达与分级、分期间差异均有统计学意义(P<0.05),与淋巴结转移有一定关系(P=0.008)。二者在BTCC中的表达呈负相关关系(P<0.05)。结论:EphA2和E-cadherin表达与BTCC生物学行为密切相关,联合检测EphA2和E-cadherin可作为判断BTCC恶性程度的指标。 Objective:To investigate the expressions and clinical significance of erythropoietin-producing human hepatocelluar A2(EphA2)and E-cadherin in bladder urothelium carcinoma(BTCC).Methods:The expressions of EphA2 and E-cadherin proteins were detected by immunohistochemisty in 50 cases of BTCC and 10 cases of normal bladder mucosa.Results:The expression of EphA2 was negative and the E-cadherin expression was normal in all the 10 normal bladder mucosa.Abnormal EphA2 and E-cadherins expressions were found in 40 and 28 cases of BTCC(80.0%,56.0%).Abnormal EphA2 expression was positively related to the grade and the stage of BTCC(P0.05),but negatively related to lymph node metastasis(P0.05).Abnormal E-cadherin expression was negatively correlated to the grade,stage(P0.05)and lymph node metastasis(P=0.008).The expression of EphA2 was inversely correlated with that of E-cadherin in BTCC(P0.05).Conclusions:The expressions of EphA2 and E-cadherin are closely related to the biological behavior of BTCC.Detection of EphA2 and E-cadherin in BTCC may have prognostic value for the degree of malignancy.
出处 《蚌埠医学院学报》 CAS 2010年第9期905-907,共3页 Journal of Bengbu Medical College
关键词 膀胱肿瘤 尿路上皮癌 生促红素人肝细胞A2 E-钙黏蛋白 免疫组织化学 bladder neoplasms urothelium carcinoma erythropoietin-producing human hepatocelluar A2 E-cadherin immunohistochemisty
  • 相关文献

参考文献13

  • 1虞颂庭,臧美孚,夏溟.尿路上皮肿瘤概论[M].见:吴阶平.泌尿外科学.济南:山东科学技术出版社,2004:919-942
  • 2Yarden Y,Ullrich A.Growth factor receptor tyrosine kinases[J].Annu Rev Biochem,1988,57:443-478.
  • 3Andres AC,Reid HH,Blaschke RJ,et al.Expression of to novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis[J].Oncogene,1994,9(5):1461-1467.
  • 4Easty DJ,Hill SP,Hsu MY,et al.Up-regulation of ephrin-A1 during melanoma progression[J].Int J Cancer,1999,84(5):494-501.
  • 5Sood AK,Seftor EA,Fletcher MS,et al.Molecular determinants of ovarian cancer plasticity[J].Am J Pathol,2001,158(4):1279-1288.
  • 6冯延平,黄涛,高军,常青,秦仁义.EphA2与E-cadherin在胰腺癌中的表达及其意义[J].中国普通外科杂志,2005,14(12):914-917. 被引量:8
  • 7张平,陈晓春,陈江,平浩,谷龙杰.EphA2和E-cadherin在前列腺癌中的表达及其意义[J].华中科技大学学报(医学版),2005,34(1):51-54. 被引量:10
  • 8崔珍,彭开桂,沈学明,江浩,张亚军,李红伟,何斌.E-钙黏蛋白在食管鳞癌中的表达及其临床意义[J].蚌埠医学院学报,2010,35(5):448-450. 被引量:2
  • 9Graff JR,Gabrielson E,Fujii H,et al.Methylation patterns of the E-cadherin 59CpG island are unstable and reflect thedynamic,heterogeneous loss of E-cadherin expression during metastatic progression[J].J Biol Chem,2000,275(4):2727-2732.
  • 10武玉东,魏金星,李中凌,吴长利,吴海.钙粘素E在膀胱移行细胞癌中的表达及意义[J].中华实验外科杂志,1999,16(1):8-9. 被引量:10

二级参考文献43

  • 1李琼,吴明富,宋安萍,魏军成,徐刚,卢运萍,马丁.浸润性乳腺导管癌组织中Ezrin和钙粘素E的表达与淋巴结转移的关系[J].癌症,2006,25(3):363-366. 被引量:53
  • 2张志发,严群,黄志勇.黏附分子cadherin与肝癌生物学特性的关系[J].世界华人消化杂志,2006,14(7):697-701. 被引量:5
  • 3王斌,徐少勇,曹淑芬,张丽,卢光新,杜勇.E-钙粘素和CD_(44)V6表达与食管癌预后的关系[J].中国现代医学杂志,2006,16(16):2468-2471. 被引量:2
  • 4孙光 陈志文 等.p53和p16蛋白在膀胱癌中的表达及预后价值[J].中华泌尿外科杂志,1999,37:270-270.
  • 5Yaldizl M,Hakverdi AU,Bayhan G,et al.Expression of E-cadherin in squamous cell carcinomas of the cervix with correlation to clinicopathological features[J].Eur J Gynaecol,2005,26(1):95-98.
  • 6Harigopal M,Berger AJ,Camp RL,et al.Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer[J].Clin Cancer Res,2005,11(11):4083-4089.
  • 7Koksal IT,Ates M,Danisman A,et al.Reduced E-cadherin and alpha-catenin expressions have no prognostic role in bladder carcinoma[J].Pathol Oncol Res,2006,12 (1):13-19.
  • 8Gonzalez MA,Pinder SE,Wencyk PM,et al.An immunohistochemical examination of the expression of E-cadherin,alpha-and beta/gamma-catenins,and alphal-and betal-integrins in invasive breast cancer[J].J Pathol,1999,187(5):523-529.
  • 9Bremnes RM,Veve R,Gabrielson E,et al.High-throughput tissue microarray analysis used to evaluate biology and prognostic of the E-cadherin pathway in non-small-cell lung cancer[J].Clin Oncol,2002,20(10):2417-2428.
  • 10Lim SC,Jang IG,Kim YC,et al.The role of E-cadherin expression in non-small cell lung cancer[J].J Korean Med Sci,2000,15(5):501-506.

共引文献51

同被引文献34

  • 1赵敏,李智,于永春,段建敏,李晶华.膀胱癌组织中上皮细胞钙依粘连蛋白基因启动子区CpG岛甲基化状态的分析[J].检验医学,2005,20(1):55-58. 被引量:6
  • 2于月成,辛晓燕,汪海丹,李红梅,李奇灵,黄侃.上皮性卵巢癌CDH1基因启动子甲基化和蛋白表达的关系及意义[J].肿瘤,2006,26(4):363-366. 被引量:3
  • 3Wang S, Li Q, Wang K, et al. Decreased expression of microRNA- 31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer [J]. Clin Transl Oncol, 2013,15(10): 849-854.
  • 4Al Hussain TO, Akhtar M, Molecular basis of urinary bladder cancer [J]. Adv Anat Patho, 2013 , 20(1):53-60.
  • 5Kitajima Y. New insights into desmosome regulation and pemphigus blistering as a desmosome-remodeling disease [J]. Kaohsiung J Med Sei, 2013,29(1): 1-13.
  • 6Pu RT, Laitala LE, Clark DP. Methylation profiling of urothelial carcinoma in bladder biopsy and urine [J]. Acta Cytol, 2011, 50(5): 499-506.
  • 7Lin HH, Ke HL, Wu WJ, et al. Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection [C]//Urologic Oneology: Seminars and Original Investiga- tions. Elsevier, 2012, 30(2): 177-181.
  • 8Yates DR, Rehman I, Abbod MF, et al. Promoter hypermethylation identifies progression risk in bladder cancer [J]. Clin Cancer Res, 2007, 13(7): 2046-2053.
  • 9Friedrich MG, Chandrasoma S, Siegmund KD, et al. Prognostic rele- vance of methylation markers in patients with non-muscle invasive bladder carcinoma [J]. Eur J Cancer, 2005, 41(17): 2769-2778.
  • 10Ribeim-Filho LA, Franks J, Sasaki M, et al. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer [J]. Mol Carcinog, 2002, 34(4): 187-198.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部